There is limited long-term comparative clinical outcome data concerning angiography-versus intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in non-complex left main coronary artery (LMCA) disease treated with the single stenting technique in the drug-eluting stent (DES) era.
U ntil recently, left main coronary artery (LMCA) disease was a hotly debated topic among interventional cardiologists as it is a challenging and risky lesion subset. According to recent guidelines, percutaneous coronary intervention (PCI) for an ostial or midshaft lesion of LMCA (non-true bifurcation) is defined as a Class IIa indication. 1) Even though LMCA disease treatment has been traditionally reserved for surgery, there have been numerous registries with drug-eluting stents (DES) that have shown favorable outcomes. 2, 3) In this uniquely challenging aspect, the use of intravascular ultrasound (IVUS) may help to evaluate the target lesion and enable optimal stent deployment during PCI; and these optimized procedural results may translate into improved long-term clinical outcomes. A recent study 4) demonstrated that the survival rate and the rate of free of major adverse cardiac events (MACE) after 3 years were higher in the IVUS group, and the incidence of stent thrombosis was lower in the IVUS group. However, recent studies did not focus on the role of IVUS in non-complex LM disease treated with the single stenting technique in the DES era. Single stenting is relatively easy, simple, and quick with angiographic guidance, but IVUS offers an edge in clearly assessing the LM lesion to ensure optimal stent expansion during PCI and takes more time and is more expensive. There is limited long-term comparative clinical outcome data concerning angiography-versus IVUS-guided PCI in non-complex LMCA disease treated with the single stenting technique in the DES era. The purpose of this study was to investigate whether angiography-guided stenting is comparable to IVUS-guided stenting during a 3-year clinical follow-up in patients with non-complex LM disease treated with the single stenting technique.
Methods
This study was a single-center, prospective, all-comer registry designed to reflect the "real world" practice since 2004. Data were collected by a trained study coordinator with a standardized case report form. This study was approved by an institutional review committee and the subjects gave informed consent. The study was performed in accordance with the ethical standards laid down in the 1964 declaration of Helsinki. Definitions: We defined single stenting as deployment of one stent confined to any site of the LM or crossing-over into the left anterior descending artery (LAD), left circumflex artery (LCX) and ramus intermedius (RI) with or without PCI in the right coronary artery (RCA). Patients with a distal LM bifurcation lesion that was treated with two stent techniques were excluded. We defined noncomplex LM coronary artery disease as LM coronary artery disease that includes isolated LM coronary artery disease or non-true distal bifurcation disease treatable with single stenting.
The PCI procedure was considered to be successful (procedural success) if the treated segment satisfied either of the following 2 success criteria: minimum lumen area (MLA) ! 9.0 mm 2 by IVUS or residual angiographic stenosis < 30% (if the minimal luminal reference vessel size by IVUS was smaller than 9.0 mm 2 ). Study population: A total of 239 consecutive patients with LM disease who underwent PCI with DES from June 2004 to February 2013 were enrolled. Among them, 43 patients were excluded because they underwent PCI with complex two stent revascularization procedures such as crushing, reverse crushing, kissing stenting, Culottes stenting, Y-stenting, V-stenting, and T-stenting with small protrusion of side branch stent technique (TAP-stenting). The remaining 196 patients treated with the single stenting technique for LM disease with either IVUS-guidance (n = 122) or angiography-guidance (n = 74) were enrolled and formed the study population. The recording of cardiovascular risk factors and past medical histories was based on patient self-report.
Diagnostic coronary angiography and PCI were performed through either the femoral or radial artery after administration of unfractionated heparin (70 -100 IU/kg). Activated clotting time was maintained above 250 seconds during the procedure. Use of IVUS was determined by the operator, and IVUS images were obtained after intracoronary injection of nitrates using a manual or automatic pullback system (0.5 mm/second) with commercially available IVUS imaging systems (40 MHz IVUS catheter, iLab, Boston Scientific). All analyses were conducted online (CASS II, Pie Medical, The Netherlands) by experienced operators. The external elastic membrane area and lumen cross-sectional areas were measured using computerized planimetry according to validated protocols.
5) The use of cilostazol (Pletaal ) or platelet glycoprotein IIb/ IIIa receptor blockers was left to the discretion of the individual operator. The use of an intra-aortic balloon pump (IABP) was at the discretion of the operator as well; prophylactic IABP support was recommended if the left ventricular ejection fraction (LVEF) was less than 40%. A successful PCI was defined as the achievement of an angiographic residual stenosis of less than 30% and final thrombolysis in myocardial infarction (TIMI) blood flow grade of 3. After stent implantation, dual antiplatelet therapy (DAPT, 100-mg daily aspirin and 75 mg daily clopidogrel) was prescribed for at least 12 months. During hospitalization, the patients were administered cardiovascular beneficial medications including DAPT, beta-blockers (BB), angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), calcium channel blockers (CCB), and lipid lowering agents (statins). After discharge, the patients were encouraged to stay on the same medication they had received during hospitalization. Study endpoints and clinical follow-up: The primary outcome was the occurrence of MACE defined as total death, non-fatal myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target vessel revascularization (Non-TVR). Total deaths were classified as cardiac in origin unless a non-cardiac cause could be documented. Non-fatal MI was defined as typical symptoms with new onset STsegment elevation or recurrent elevation of serum cardiac markers at least over twice the upper limit. TLR of the target lesion due to restenosis or reocclusion within the stent or 5 mm in and adjacent to the stent was defined as revascularization of the distal or proximal segment. TVR was defined as a revascularization of the target vessel or any segment of the target lesion containing the coronary stent. All participants were required to visit the outpatient department of cardiology at the end of the first month and then every 3 to 6 months after the index PCI procedure as well as whenever angina-like symptoms occurred. The cumulative incidence of various individual and composite clinical outcomes during the 3-year clinical follow-up was compared between the two groups. Statistical analysis: For continuous variables, differences between the two groups were evaluated with the unpaired t-test or Mann-Whitney rank test. Data are expressed as the mean ± standard deviation. For discrete variables, differences are expressed as counts and percentages and were analyzed with the chi-square test or Fisher's exact test between the two groups. To adjust for any potential confounders, propensity score (PS) analysis was performed using the logistic regression model. We tested all available variables that could be of potential relevance: age, gender, LVEF, initial diagnosis, prior history of coronary artery disease, risk factors of coronary artery disease (hypertension, diabetes, chronic kidney disease, cerebrovascular accident, peripheral artery disease, Medina Kim, ET AL Values are mean ± SD or n (%). For continuous variables, differences between the two groups were evaluated with the unpaired t-test or Mann-Whitney rank test and discrete variables were analyzed with the chi-square test or Fisher's exact test between the two groups. LVEF indicates left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CK, creatine kinase; and CRP, C-reactive protein.
classification, concomitant right coronary artery disease, reference diameter of LM coronary artery, total lesion length, total stent length, small vessel disease, diffuse long lesion, deployed stent type, chronic total obstructive (CTO) lesion, final kissing ballooning, cardiogenic shock, and the use of IABP). The PS was estimated using the Cstatistic for the logistic regression model and the propensity score for the two groups was 0.835. Various clinical outcomes were estimated with the Kaplan-Meier method, and differences between the two groups were compared with the log-rank test. Proportional hazard models were used to assess the hazard ratio of the IVUS guided group compared with the angiography guided group adjusted PS. All data were processed with SPSS (version 20.0, SPSS-PC, Inc. Chicago, IL, USA).
Results
The study population included 196 eligible patients with non-complex LMCA disease treated with the single stenting technique using DES. Baseline clinical characteristics, laboratory findings, and angiographic characteristics are summarized in Table I and Table II . The mean age of the angiography-guided group was 64.8 ± 11.3 years versus 62.1 ± 10.6 years (P = 0.041) in the IVUS-guided group. Patients in the angiography-guided group had a significantly lower LVEF (49 ± 13% versus 55 ± 9%, P = 0.001). There were no significant differences in initial diagnosis, history of coronary artery disease, or other cardiovascular risk factors. The incidence of cardiogenic shock patients was not different between the two groups (0.8% versus 1.4%, P = 0.720). The serum troponin T ANGIO-GUIDED SINGLE STENTING FOR NON-COMPLEX LMCA Values are mean ± SD or n (%). For continuous variables, differences between the two groups were evaluated with the unpaired t-test or Mann-Whitney rank test and discrete variables were analyzed with the chi-square test or Fisher's exact test between the two groups. MLD indicates minimal luminal diameter; DES, drug-eluting stent; IABP, intra-aortic balloon pump; and NS, not significant (> 0.999).
level was significantly higher in the angiography-guided group compared with the IVUS-guided group (0.91 ± 1.82 ng/dL versus 0.34 ± 0.91 ng/dL, P = 0.045). The Medina lesion distribution classification of LM coronary artery disease was similar between the two groups (Table II) .
The reference vessel diameter of LMCA was larger in the IVUS-guided group (3.61 ± 0.51 mm versus 3.38 ± 0.52 mm, P = 0.002). The significant difference in the post-PCI minimal luminal diameter (MLD) was probably due to the use of IVUS to select the most appropriate stent size to be deployed. 
Values are numbers and percentages. Variables were analyzed with the chi-square test or Fisher's exact test between the two groups bined treatment of RCA (27.9% versus 27.0%, P = 0.898) or RI (0.8% versus 1.4%) was also similar between the two groups. When we considered combined CTO lesions, a LAD coronary artery CTO lesion was more frequently combined in the angiography-guided PCI group (9.5% versus 1.6%, P = 0.011). Table III shows the periprocedural complication rates of PCI. However, there was no significant difference in the complication rates between the two groups. The types of post-PCI medications, including aspirin, clopidogrel, cilostazol (Pletaal , Otsuka Cumulative event curves were generated with the Kaplan-Meier method and compared by the log-rank test (right upper small box). The individual propensity score was incorporated into Cox-proportional hazard regression models as a covariate as well as the IVUS-guided PCI group to calculate the adjusted HR.
Pharmaceutical Co., Tokyo), ARB, ACEI, BB, CCB, and lipid lowering agents were similar between the two groups (Table IV) . The 30-day clinical outcomes are shown in Table V . At 30 days, 10 deaths, 7 MIs, and 1 revascularization occurred in the angiography-guided PCI group; and 5 deaths and 3 MIs occurred in the IVUS-guided PCI group. There were 9 cardiac deaths in the angiography-guided PCI group and 3 cardiac deaths in the IVUS-guided PCI group. Although the unadjusted rates of total death (13.5% versus 4.1%, P = 0.011) and cardiac death (12.2% versus 2.5%, P = 0.006) were significantly different between the two groups, the PS adjusted Cox-proportional hazard ratio (HR) showed no significant difference in the incidence of total death (HR: 0.63, 95% CI: 0.18-2.26; P = 0.479) and cardiac death (HR: 0.50, 95% CI: 0.11-2.28; P = 0.368) ( Table V) . Among the patients with MI, 3 out of 9 patients (33.3%) in the angiography-guided PCI group and 2 out of 3 patients (67%) in the IVUS-guide group were STEMI. The cause of non-cardiac death in the angiography-guided PCI group was chronic kidney disease. Septic shock and cerebral hemorrhage were the causes of non-cardiac death in IVUS-guided PCI group.
The incidence of non-fatal MI was also higher in the angiography-guided PCI group (9.5% versus 2.6%, P = 0.044) before adjustment. After adjustment, the incidence of non-fatal MI was not significantly different between the two groups (HR: 0.47, 95% CI: 0.06-3.52; P = 0.459). Also, the PS adjusted incidence of MACE was not significantly different between the two groups (HR: 0.53, 95% CI: 0.15-1.84; P = 0.314).
The 3-year cumulative major clinical outcomes are shown in Figure 1 and Figure 2 . Various clinical outcomes were estimated with the Kaplan-Meier method, and differences between the two groups were compared with the log-rank test. Although Kaplan-Meier analysis showed significant differences in the incidence of total death (7% versus 22%; P = 0.002 by log-rank test) and cardiac death (3.3% versus 18%; P = 0.001 by long-rank test) between the two groups, the PS-adjusted Cox-proportional HR was not significantly different between the two groups both in total death (HR: 0.45, 95% CI: 0.16-1.23; P = 0.124) and cardiac death (HR: 0.37, 95% CI: 0.10-1.35; P = 0.133). The incidence of MI was similar between the two groups both before (10% versus 3.6%; P = 0.086 by log-rank test) and after adjustment (HR: 0.46, 95% CI: 0.13-2.52; P = 0.463, Figure 1 ). The incidence of TLR (20% versus 6%; P = 0.006 by log-rank test, HR: 0.34, 95% CI: 0.20-1.75; P = 0.346) and combined incidence of TVR and non-TVR (25% versus 14%; P = 0.001 by log-rank test, Kim, ET AL Figure 2 . Outcomes for overall groups: TLR, TVR, Non-TVR, and MACE. A: Cumulative event curves of TLR (%). B: Cumulative event curves of TVR and Non-TVR (%). C: Cumulative event curves of MACE (%). TLR indicates target lesion revascularization; TVR, target vessel revascularization; Non-TVR, non-target vessel revascularization; MACE, major adverse cardiac events; IVUS, intravascular ultrasound; HR, hazard ratio; and CI, confidence interval. Cumulative event curves were generated with the Kaplan-Meier method and compared by the log-rank test (right upper small box). The individual propensity score was incorporated into Cox-proportional hazard regression models as a covariate as well as the IVUS-guided PCI group to calculate the adjusted HR. HR: 0.70, 95% CI: 0.30-1.63; P = 0.417) also showed similar results as before (Figure 2) . Kaplan-Meier analysis showed a significant difference between the two groups in the incidence of MACE before adjustment (43% versus 21%; P = 0.001 by log-rank test). However, the PS adjusted Cox-proportional HR showed no significant difference between the two groups (HR: 0.63, 95% CI: 0.33-1.17; P = 0.149).
Discussion
The main finding from this study is that angiography-guided PCI for non-complex LMCA diseases treated with the single stenting technique showed results comparable to those with IVUS-guided PCI in reducing clinical events during 3-year clinical follow-up in the DES era.
LMCA intervention remains a clinical challenge. With advancements in technology, devices including newer generation DES, antiplatelet agents, operator experience, and more extensive use of IVUS, many clinical trials have shown favorable outcomes. 6, 7) However, recent studies did not focus on the role of IVUS in non-complex LMCA disease treated with single stenting technique. Single stenting is relatively easy and quick when performed an angiography-guided procedure. IVUS imaging has the advantage of providing detailed cross-sectional images within the vessel lumen, allowing better evaluation of stent expansion and optimal stent landing in proximal and distal target lesions. [8] [9] [10] We believe the IVUS-guided improvement in the angiographic MLD was the mechanism responsible for the reduced restenosis, reduced repeat revascularization, and reduced MACE. The DIPO study 11) and the TULIP study 12) also suggested that IVUS-guided PCI could reduce restenosis and MACE. However, the OPTICUS study 13) did not show an effect of IVUS guidance on restenosis. The OPTICUS study investigators explained that the unexpectedly good acute results in the angiographic-guided group were due to the extensive experience with IVUS among the OPTICUS investigators, which might have affected the method used to implant the stents under angiographic guidance. However, IVUS-guided PCI could not always achieve perfect stent optimization even in noncomplex lesions. In the AVID trial 14) the number of patients that met a minimal stent area above 90% of the reference vessel was only 44%. Approximately 80% of the study population's minimum stent area was above 80% of the average of the proximal and distal reference lumen area in RESIST. 15) However, in our study, the mean ratio of post-stent diameter over reference vessel diameter in LMCA was 93.9% in the IVUS-guided PCI group compared with 91.1% in the angiography-guided PCI group. Previous IVUS studies have shown stent under-expansion to be a contributing factor to adverse clinical outcomes after DES implantation, 16, 17) though published randomized trial data for IVUS-guided DES implantation does not currently exist. Several reports indicated that IVUS guidance improves clinical outcomes following DES implantation in patients with LMCA disease 18) and bifurcation lesions. 19) In the DES era, IVUS may play an important role in the treatment of complex coronary artery disease. 20, 21) However, there is little data about long-term clinical outcomes of IVUS-guided non-complex LMCA disease treated with a single stenting technique. Although the sample size was small, Agostoni, et al. 22) showed that there were no differences in the incidence of MACE comprising death, MI, or TVR. Agostoni, et al. also commented that the anatomic location of the atherosclerotic disease in LMCA disease was the only independent predictor of MACE during follow-up period and when ostial or mid-LMCA disease is treated with DES, the incidence of MACE is particularly low. Park, et al. 18) reported that IVUS-guided PCI may reduce the long-term mortality rate for unprotected LMCA disease compared with conventional angiography guidance. However, they could not explain the precise mechanism of the late mortality benefit of using IVUS-guided PCI. Roy, et al. 23) proposed that using IVUS guidance may improve the long-term survival rate by reducing the risk of stent thrombosis in DES treatment. Park, et al. 18) mentioned that the superior benefit of IVUS guidance in DES treatment was not consistently observed in the other Cox model using PS as a covariate for all patients. In our study, as a whole, two cases of stent thrombosis occurred during the 3-year follow-up period. One case occurred in the IVUS-guided PCI group and the other in the angiography-guided PCI group. Compared with a two-stent strategy, a one-stent strategy causes a relatively lower frequency of stent thrombosis. Two-stent deployment may increase the risk of stent thrombosis and repeat revascularization in bifurcation LMCA lesions. 24, 25) In our study, as shown in the Kaplan-Meier survival curve (Figure 1 ), most deaths occurred before 1 year after index PCI. If very late stent thrombosis had occurred more frequently in our study, the rates of MACE may have revealed different results. We used PS as a covariate for all patients so our study results may have a meaningful message in the treatment strategy for non-complex LMCA disease treated with single stenting. The authors had included relatively high-risk patients such as those with MI, cardiogenic shock, IABP insertion, diffuse long lesions, and combined CTO lesions in our study. However, the total number of these high risk patients was relatively small and their distributions were not significantly different between the two groups.
In our study, the baseline LVEF was significantly lower, the total stent length was longer, and combined LAD CTO lesions were more frequent in the angiography-guided PCI group than the IVUS-guided PCI group. In contrast the baseline reference diameter of LMCA was larger in the IVUS-guided group. However, the major clinical outcomes between these two groups were similar during the 3-year clinical follow-up period after adjustment of baseline differences. We think that these comparable results may be due to the fact the target lesion was non-complex LMCA disease. In other words, the major clinical outcomes might be poorer in angiography-guided PCI groups compared with IVUSguide PCI groups in cases of complex LMCA disease, especially in distal LMCA true bifurcation lesions. We totally agree with the beneficial effect of IVUS during PCI for true bifurcation lesions of LMCA.
In general, IVUS-guided PCI required a longer procedure time than angiography-guided PCI. However, the procedure times were similar between the two groups in our study. These results may originate from the relatively poorer baseline characteristics of the angiography-guided group, such as lower LVEF, longer total stent length, smaller baseline reference diameter of LMCA, and higher rates of combined LAD CTO lesions. Conversely, the IVUS-guided group had relatively shorter stent length, larger reference diameter, and a lower incidence of combined LAD CTO, suggesting shorter IVUS examination times which reflect similar procedure times between the two groups. In addition, if the number of enrolled patients was larger, and if the operators were not experienced, the procedure time might have been different.
Previous studies 6, 18, 23, [26] [27] [28] did not have a primary focus on the clinical outcomes of non-complex LMCA disease treated with a single stenting technique. Only Agostoni, et al. 22) reported that when ostial or mid-LMCA disease is treated with DES, the rate of cardiac events is particularly low. Compared to the two-stent technique, the one-stent technique is a relatively simple technique which may lead to good clinical outcomes and less recurrence. Although IVUS guidance has been strongly recommended in LMCA treatment, our results afford the time to think about whether routine use of IVUS is mandatory to optimize clinical outcomes, especially in cases of single stenting. The authors totally agree that the anatomic location of the atherosclerotic disease in LMCA is a very important independent predictor of events during follow-up as Agostoni, et al mentioned. At times during PCI we frequently met unexpected factors such as patient economic problems, procedure which require reduce the time, and so on. In Korea, currently there is no reimbursement program for IVUS in addition to coronary angiography. We think our study results may provide cost-effective clinical implications for an angiography-guided simple stenting technique for simple LM disease in real world clinical practice. However, this study is hypothesis generating and future randomized studies with larger study populations will be needed before drawing any final conclusions. Study limitations: Our study has several limitations. It was a non-randomized, single-center, observational study and the sample size was relatively small. We can see some trends of lower incidences of major adverse events in the IVUS-guided PCI group and we can image that if we enrolled more patients, we may obtain different results. Future large-scale randomized studies with sufficient sample sizes are warranted. Like every "real-world" registry, there may have been some under-reporting and/or missing data.
The determination of IVUS-guided PCI or angiographyguided PCI was at the discretion of the operator. IVUS guided PCI might be selected for lesions in more complex coronary anatomy and operator level bias remains a limitation as well. We feel, however, this has great advantages in that it reflects real and routine hospital clinical practice. Conclusions: Angiography-guided PCI for non-complex LMCA diseases treated with a single stenting technique showed comparable results compared with IVUS-guided PCI in reducing clinical events during 3-year clinical follow-up in the DES era. Although IVUS guided PCI is the ideal strategy, angiography-guided PCI can be an option for LMCA PCI in some selected cases.
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